Recombinant polypeptides having Ph1 p I epitope antigenicity and methods of diagnosing allergy in vitro
    11.
    发明授权
    Recombinant polypeptides having Ph1 p I epitope antigenicity and methods of diagnosing allergy in vitro 有权
    具有Ph1 p I表位抗原性的重组多肽和在体外诊断变态反应的方法

    公开(公告)号:US07148019B2

    公开(公告)日:2006-12-12

    申请号:US10161660

    申请日:2002-06-05

    摘要: A recombinant DNA molecule comprising a nucleotide sequence (I) which codes for a polypeptide displaying the antigenicity of one, two or more of the Phl p I epitope clones (28, 34, 41, 42, 43, 45, 50, 52, 64, 80, 85, 86, 95, 97, 98, 103, 108, 109, 113, 114), with the amino acid sequences defined in SEQ ID NOS: 5, 7, 9 and 12–28, and preferably being derived from grasses or monocotyledonic plants, or a nucleotide sequence (II) which hybridizes with such a nucleotide sequence (I) under conditions of high, stringency. Polypeptides displaying the antigenicity of one, two or more of the Phl p I epitope clones (28, 34, 41, 42, 43, 50, 52, 64, 80, 85, 86, 95, 97, 98, 103, 108, 109, 113, 114). Recombinant expression vectors containing the recombinant molecule and host cells transformed with the vector. Diagnostic methods based on utilizing the polypeptides in immunoassays for humoral antibodies and cellular reactions.

    摘要翻译: 一种重组DNA分子,其包含核苷酸序列(I),其编码显示一种,两种或更多种Phl p I表位克隆(28,34,41,42,43,45,50,52,64)的抗原性的多肽 ,80,85,86,95,97,98,103,108,109,113,114),其氨基酸序列在SEQ ID NO:5,7,9和12-28中定义,优选衍生自 草或单子叶植物,或在高度严格的条件下与这种核苷酸序列(I)杂交的核苷酸序列(II)。 显示一种,两种或更多种Phl p I表位克隆(28,34,41,42,43,50,52,64,80,85,86,85,97,98,103,108, 109,113,114)。 含有载体转化的重组分子和宿主细胞的重组表达载体。 基于在免疫测定中利用多肽进行体液抗体和细胞反应的诊断方法。

    Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
    12.
    发明授权
    Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments 有权
    重组变应原,其片段,相应的重组DNA分子,含有DNA分子的载体和宿主,所述变应原和片段的诊断和治疗用途

    公开(公告)号:US06559120B2

    公开(公告)日:2003-05-06

    申请号:US09811672

    申请日:2001-03-20

    IPC分类号: A61K3804

    摘要: A recombinant DNA molecule comprising a nucleotide sequence (I) which codes for a polypeptide displaying the antigenicity of one, two or more of the Phi p I epitope clones (28, 34, 41, 42, 43, 45, 50, 52, 64, 80, 85, 86, 95, 97, 98, 103, 108, 109, 113, 114), with the amino acid sequences defined in SEQ ID NOS: 5, 7, 9 and 12-28, and preferably being derived from grasses or monocotyledonic plants, or a nucleotide sequence (II) which hybridizes with such a nucleotide sequence (I) under conditions of high stringency. Polypeptides displaying the antigenicity of one, two or more of the Phi p I epitope clones (28, 34, 41, 42, 43, 50, 52, 64, 80, 85, 86, 95, 97, 98, 103, 108, 109, 113, 114). Recombinant expression vectors containing the recombinant molecule and host cells transformed with the vector. Diagnostic methods based on utilizing the polypeptides in immunoassays for humoral antibodies and cellular reactions.

    摘要翻译: 一种重组DNA分子,其包含核苷酸序列(I),其编码显示一种,两种或更多种Phi I表位克隆(28,34,41,42,43,45,50,52,64)的抗原性的多肽 ,80,85,86,95,97,98,103,108,109,113,114),其氨基酸序列在SEQ ID NO:5,7,9和12-28中定义,优选衍生自 草或单子叶植物,或在高度严格条件下与这种核苷酸序列(I)杂交的核苷酸序列(II)。 显示一种,两种或更多种Phi p I表位克隆(28,34,41,42,43,50,52,64,80,85,86,85,97,98,103,108,108, 109,113,114)。 含有载体转化的重组分子和宿主细胞的重组表达载体。 基于在免疫测定中利用多肽进行体液抗体和细胞反应的诊断方法。

    Recombinant allergen, fragments thereof, corresponding recombinant DNA
molecules, vectors and hosts containing the DNA molecules
    13.
    发明授权
    Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules 失效
    重组变应原,其片段,相应的重组DNA分子,含有DNA分子的载体和宿主

    公开(公告)号:US6008340A

    公开(公告)日:1999-12-28

    申请号:US750419

    申请日:1997-01-14

    摘要: A recombinant DNA molecule comprising a nucleocide sequence (I) which codes for a polypeptide displaying the antigenicity of one, two or more of the Phl p I epitope clones (28, 34, 41, 42, 43, 50, 52, 64, 80, 85, 86, 95, 97, 98, 103, 108, 109, 113, 114), with the amino acid sequences defined in SEQ ID NOS: 5, 7, 9 and 12-28, and preferably being derived from grasses or monocotyledonic plants, or a nucleotide sequence (II) which hybridizes with such a nucleotide sequence (I) under conditions of high stringency. Polypeptides displaying the antigenicity of one, two or more of the Phl p I epitope clones (28, 34, 41, 42, 43, 50, 52, 64, 80, 85, 86, 95, 97, 98, 103, 108, 109, 113, 114). Recombinant expression vectors containing the recombinant molecule and host cells transformed with the vector. Diagnostic methods based on utilizing the polypeptides in immunoassays for humoral antibodies and cellular reactions.

    摘要翻译: PCT No.PCT / SE95 / 00724 Sec。 371日期1997年1月14日 102(e)日期1997年1月14日PCT Filed 1995年6月14日PCT公布。 出版物WO95 / 34578 日期1995年12月21日一种重组DNA分子,其包含核苷酸序列(I),其编码显示一种,两种或更多种Phl p I表位克隆的抗原性的多肽(28,34,41,42,43,50, 52,64,80,85,86,95,97,98,103,108,109,113,114),其氨基酸序列在SEQ ID NO:5,7,9和12-28中定义,优选地 或衍生自草或单子叶植物的核苷酸序列(II),其与高度严格条件下的这种核苷酸序列(I)杂交。 显示一种,两种或更多种Phl p I表位克隆(28,34,41,42,43,50,52,64,80,85,86,85,97,98,103,108, 109,113,114)。 含有载体转化的重组分子和宿主细胞的重组表达载体。 基于在免疫测定中利用多肽进行体液抗体和细胞反应的诊断方法。